TT has received initial orders for devices and testing cartridges which will be delivered to potential launch customers in September and October 2020. It will invest up to £5m to support this phase of the programme and the launch of Virolens globally, and additional device production and cartridge assembly may also take place at other TT locations, as required.
Related Covid-19 articles
- US ENDS PHILIPS VENTILATOR CONTRACT EARLY
- UK TEST SYSTEMS TO BE BUILT IN THE NETHERLANDS BY US COMPANY
- LAB-ON-A-CHIP STARTUP GETS TEST BOOST
Other articles on eeNews Europe